BigBear.ai director Dorothy Hayes sold 15,000 shares of the company's stock on May 8, pocketing $61,575 at an average price of $4.105 per share. The transaction, disclosed in a Form 4 filing with the SEC, left her with 204,150 shares in her portfolio.
The sale comes just days after BigBear.ai reported a significant increase in its backlog, which jumped 14% sequentially to $281.9 million, largely driven by a $53 million sole-source classified contract. The company also reaffirmed its full-year 2026 revenue guidance of $135 million to $165 million.
First-Quarter Results
BigBear.ai posted first-quarter revenue of $34.4 million, down 1% year-over-year. However, gross margin improved sharply to 34.0% from 21.3% in the same period last year. Chief Executive Kevin McAleenan highlighted nearly $75 million in first-quarter gains, stating the results keep the company on track for its 2026 revenue target.
Chief Financial Officer Sean Ricker pointed to strong gross margin expansion tied to generative AI revenue, which involves AI technology that produces text, analysis, or other outputs from data and prompts.
Market Context
BBAI stock traded near $4.18 on the day of the filing, down 27% over the past six months despite some recent momentum. The company's market capitalization stood at approximately $2.0 billion, far behind Palantir Technologies' $347 billion valuation but ahead of C3.ai at $1.36 billion.
BigBear.ai's revenue remains heavily dependent on federal contracts, with $29.9 million of its $34.4 million first-quarter revenue coming from U.S. government sources. The company's 10-Q filing flagged exposure to shifts in government funding, procurement agendas, budget approvals, and potential program delays.
Insider Transaction Details
Hayes sold roughly 6.8% of her direct stake in the company. The Form 4 filing did not specify a reason for the sale, which was marked with transaction code 'S' for an open market sale. The SEC requires directors, officers, and holders of more than 10% of a registered equity class to file such disclosures within two business days.
Investors are now weighing the director's share sale against management's optimistic outlook on backlog growth, lower interest costs, and increasing revenue from generative AI products. The key question remains whether the company can convert its growing backlog into actual revenue quickly enough to reduce losses and validate its defense AI narrative.
